These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27318489)

  • 21. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
    Ferrini W; Ambresin A
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
    Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study.
    Yoon YH; Kim JW; Lee JY; Kim IT; Kang SW; Yu HG; Koh HJ; Kim SS; Chang DJ; Simonyi S
    Ophthalmologica; 2018; 240(2):81-89. PubMed ID: 29642062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RELATIONSHIP BETWEEN RETINAL THICKNESS AND VISUAL ACUITY IN EYES WITH RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANT.
    Danis RP; Sadda S; Jiao J; Li XY; Whitcup SM
    Retina; 2016 Jun; 36(6):1170-6. PubMed ID: 26655606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Singer MA; Capone A; Dugel PU; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Apr; 15():33. PubMed ID: 25885285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Dexamethasone Intravitreal Implant for Treatment of Refractory Macular Edema Secondary to Retinal Vein Occlusion in Taiwan.
    Sheu SJ; Wu TT; Horng YH
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):461-7. PubMed ID: 26067779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
    Reid GA; Sahota DS; Sarhan M
    Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Altunel O; Göktaş A; Duru N; Özköse A; Arifoğlu HB; Ataş M
    Semin Ophthalmol; 2018; 33(2):179-184. PubMed ID: 27599562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
    Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.
    Kuppermann BD; Haller JA; Bandello F; Loewenstein A; Jiao J; Li XY; Whitcup SM
    Retina; 2014 Sep; 34(9):1743-9. PubMed ID: 24830824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal ranibizumab and/or dexamethasone implant for macular edema secondary to retinal vein occlusion.
    Nghiem-Buffet S; Fajnkuchen F; Buffet M; Ayrault S; Le Gloahec-Lorcy A; Grenet T; Delahaye-Mazza C; Quentel G; Cohen SY
    Ophthalmologica; 2014; 232(4):216-22. PubMed ID: 25413000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex®) in macular edema due to retinal vein occlusion.
    Parravano M; Oddone F; Boccassini B; Giorno P; Chiaravalloti A; Tedeschi M; Scarinci F; Varano M
    Ophthalmic Res; 2014; 51(3):153-60. PubMed ID: 24642474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion.
    Pichi F; Specchia C; Vitale L; Lembo A; Morara M; Veronese C; Ciardella AP; Nucci P
    Am J Ophthalmol; 2014 Mar; 157(3):607-15.e1. PubMed ID: 24528934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion.
    Parodi MB; Iacono P; De Benedetto U; Cascavilla M; Bandello F
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):566-8. PubMed ID: 22746671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monthly microperimetry (MP1) measurement of macular sensitivity after dexamethasone implantation (Ozurdex) in retinal vein occlusions.
    Winterhalter S; Vom Brocke GA; Klamann MK; Müller B; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1873-82. PubMed ID: 25576170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment.
    Altunel O; Duru N; Goktas A; Ozkose A; Goktas E; Atas M
    Int Ophthalmol; 2017 Apr; 37(2):333-339. PubMed ID: 27221365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up.
    Meyer LM; Schönfeld CL
    J Ocul Pharmacol Ther; 2013; 29(6):560-5. PubMed ID: 23480270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optical coherence tomography angiography in retinal vein occlusion treated with dexamethasone implant: a new test for follow-up evaluation.
    Glacet-Bernard A; Sellam A; Coscas F; Coscas G; Souied EH
    Eur J Ophthalmol; 2016 Aug; 26(5):460-8. PubMed ID: 27405288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.